Corporate Banner
Satellite Banner
Technology Networks Header
Tuesday, July 29, 2014
Register | Sign in
Home Page>News

  News Archive

Dezima Extends Clinical Development Program for its CETP Inhibitor TA-8995
Thursday, July 10, 2014
Phase 2b TULIP study readout in August 2014, new Lipoprotein(a) study approved.

Baxter Acquires AesRx, LLC
Thursday, July 10, 2014
Program carries potential to address significant unmet patient need.

AAIPharma and CML Appoints CEO
Thursday, July 10, 2014
Appointment of Stephan Kutzer as Chief Executive Officer, effective August 1, 2014.

Lightlake Signs Agreement with Commercial Contract Manufacturer
Thursday, July 10, 2014
Agreement to commence production of naloxone-based opioid overdose reversal treatment.

Portola Enters into Clinical Collaboration Agreement with Daiichi Sankyo
Thursday, July 10, 2014
Phase 3 collaboration agreements in place with all direct Factor Xa inhibitor manufacturers while Portola retains all rights to andexanet alfa.

Waters, Chinese Pharmacopeia Commission Establish Joint Open Laboratory
Thursday, July 10, 2014
Located in the laboratory building of Beijing Zhendong Guangming Drug Research Institute, the new facility is over 400m2.

Penn Researchers: Consider the ‘Anticrystal’
Wednesday, July 09, 2014
The study published in Nature Physics was conducted by Andrea Liu, Carl Goodrich and Sidney Nagel.

ALMSCO International Merges with Markes International
Tuesday, July 08, 2014
Markes’ mass spectrometry division merges into core business operations.

Researchers Regrow Human Corneas
Tuesday, July 08, 2014
Limbal stem cells - identified with a new marker - could reverse a leading cause of blindness.

<< 11 12 13 14 15 16 17 >>
Showing Results 131 - 140 of 26211
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to